NEW ANTIBACTERIAL DRUGS FOR THE TREATMENT OF MYCOBACTERIAL DISEASE IN MAN

被引:32
作者
MITCHISON, DA
ELLARD, GA
GROSSET, J
机构
[1] NATL INST MED RES,LEPROSY & MYCOBACTERIAL RES LAB,LONDON NW7 1AA,ENGLAND
[2] PITIE SALPETRIERE SCH MED,DEPT BACTERIOL & VIROL,PARIS,FRANCE
关键词
D O I
10.1093/oxfordjournals.bmb.a072281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:757 / 774
页数:18
相关论文
共 51 条
[1]   INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS, MYCOBACTERIUM-FORTUITUM AND MYCOBACTERIUM-CHELONEI TO AUGMENTIN [J].
CASAL, M ;
RODRIGUEZ, F ;
BENAVENTE, M ;
LUNA, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (04) :453-454
[2]  
COLSTON MJ, 1978, LEPROSY REV, V49, P7
[3]   INVITRO ACTIVITY OF AMOXICILLIN IN COMBINATION WITH CLAVULANIC ACID AGAINST MYCOBACTERIUM-TUBERCULOSIS [J].
CYNAMON, MH ;
PALMER, GS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (03) :429-431
[4]  
DELLABRUNA C, 1983, J ANTIBIOT, V36, P1502
[5]  
DICKINSON JM, 1981, AM REV RESPIR DIS, V123, P367
[6]   INVITRO ACTIVITY OF NEW RIFAMYCINS AGAINST RIFAMPICIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS AND MAIS-COMPLEX MYCOBACTERIA [J].
DICKINSON, JM ;
MITCHISON, DA .
TUBERCLE, 1987, 68 (03) :177-182
[7]   INVITRO OBSERVATIONS ON THE SUITABILITY OF NEW RIFAMYCINS FOR THE INTERMITTENT CHEMOTHERAPY OF TUBERCULOSIS [J].
DICKINSON, JM ;
MITCHISON, DA .
TUBERCLE, 1987, 68 (03) :183-193
[8]   INVITRO PROPERTIES OF RIFAPENTINE (MDL473) RELEVANT TO ITS USE IN INTERMITTENT CHEMOTHERAPY OF TUBERCULOSIS [J].
DICKINSON, JM ;
MITCHISON, DA .
TUBERCLE, 1987, 68 (02) :113-118
[9]  
Fox W., 1985, Bulletin of the International Union Against Tuberculosis, V60, P40
[10]  
GUELPALAURAS CC, 1987, INT J LEPROSY, V55, P70